Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
silvia.mezi@uniroma1.it
Silvia Mezi
Ricercatore
Struttura:
DIPARTIMENTO DI SCIENZE RADIOLOGICHE, ONCOLOGICHE E ANATOMO-PATOLOGICHE
E-mail:
silvia.mezi@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis
BMC CANCER
2024
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis
BMC CANCER
2024
Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology
FRONTIERS IN ONCOLOGY
2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach
CANCER IMMUNOLOGY, IMMUNOTHERAPY
2023
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors
FRONTIERS IN IMMUNOLOGY
2023
The impact of drug–drug Interactions on the toxicity profile of combined treatment with BRAF and MEK Inhibitors in patients with BRAF-mutated metastatic melanoma
CANCERS
2023
Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up
DIAGNOSTICS
2022
Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up
DIAGNOSTICS
2022
Genomic and immune approach in platinum refractory HPV-negative head and neck squamous cell carcinoma patients treated with Immunotherapy: a novel combined profile
BIOMEDICINES
2022
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy
FRONTIERS IN IMMUNOLOGY
2022
The role of opioids in cancer response to immunotherapy
JOURNAL OF TRANSLATIONAL MEDICINE
2021
Standard of care and promising new agents for the treatment of mesenchymal triple-negative breast cancer
CANCERS
2021
A new medical record proposal to the prognostic risk assessment for mronj in oncologic patients: “Sapienza head and neck unit” proposal
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
2021
Myocardial metastasis of tongue cancer: a rare localization
THE AMERICAN JOURNAL OF CASE REPORTS
2021
Management of a rare case of squamous cell carcinoma of the tongue in a patient affected by progeria
ORAL ONCOLOGY
2021
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era
JOURNAL OF TRANSLATIONAL MEDICINE
2021
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study
JOURNAL OF PERSONALIZED MEDICINE
2021
Anti–PD-1 and Anti–PD-L1 in head and neck cancer: a network meta-analysis
FRONTIERS IN IMMUNOLOGY
2021
Prediction of recurrence by Machine learning in salivary gland cancer patients after adjuvant (chemo)radiotherapy
IN VIVO
2021
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL
VACCINES
2020
1
2
3
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma